Insider Purchases of Penny Stocks -
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2018-11-29 | AAC | Aac Holdings, Inc. | Nanko Michael | Pres, COO | P - Purchase | $2.18 | +21,000 | 71,200 | +42% | +$45,870 | |||||
2018-11-29 | AAC | Aac Holdings, Inc. | Cash W Larry | Dir | P - Purchase | $2.23 | +25,000 | 60,000 | +71% | +$55,750 | ||||||
2018-11-29 | AAC | Aac Holdings, Inc. | Freeman Darrell S. | Dir | P - Purchase | $2.19 | +25,000 | 269,433 | +10% | +$54,750 | ||||||
2018-11-15 | ACRX | Acelrx Pharmaceuticals Inc | Edwards Mark G | Dir | P - Purchase | $2.82 | +20,700 | 181,000 | +13% | +$58,376 | ||||||
2018-11-13 | ACRX | Acelrx Pharmaceuticals Inc | Asadorian Raffi | CFO | P - Purchase | $3.13 | +5,000 | 47,000 | +12% | +$15,646 | ||||||
2018-11-19 | ACRX | Acelrx Pharmaceuticals Inc | Palmer Pamela P | Chief Medical Officer | P - Purchase | $3.07 | +16,000 | 472,134 | +4% | +$49,120 | ||||||
| M | 2018-11-19 | ACTG | Acacia Research Corp | Tobia Alfred Victor Jr. | Dir | P - Purchase | $3.03 | +65,346 | 1,155,346 | +6% | +$198,033 | |||||
2018-11-19 | AGFS | Agrofresh Solutions, Inc. | Dowdupont Inc. | 10% | P - Purchase | $4.77 | +36,081 | 21,001,151 | 0% | +$171,951 | ||||||
| M | 2018-11-15 | AGFS | Agrofresh Solutions, Inc. | Dowdupont Inc. | 10% | P - Purchase | $4.88 | +66,220 | 20,965,070 | 0% | +$322,945 | |||||
2018-11-30 | AIRI | Air Industries Group | Richmond David S. | See Footnote 1, 10% | P - Purchase | $3.37 | +4,504 | 886,843 | +1% | +$15,160 | ||||||
| M | 2018-11-23 | AKAO | Achaogen, Inc. | Duggan Robert W | 10% | P - Purchase | $1.79 | +157,760 | 8,623,955 | +2% | +$281,606 | |||||
2018-11-20 | AKAO | Achaogen, Inc. | Duggan Robert W | 10% | P - Purchase | $1.93 | +231,495 | 8,466,195 | +3% | +$446,947 | ||||||
2018-11-27 | AKS | Ak Steel Holding Corp | Newport Roger K | CEO | P - Purchase | $3.03 | +10,000 | 461,297 | +2% | +$30,300 | ||||||
2018-11-09 | AKTS | Akoustis Technologies, Inc. | Miller Steven P | Dir | P - Purchase | $4.70 | +20,000 | 133,824 | +18% | +$94,000 | ||||||
2018-11-08 | AKTS | Akoustis Technologies, Inc. | Neal Jerry D | Dir | P - Purchase | $5.00 | +40,000 | 620,828 | +7% | +$200,000 | ||||||
2018-11-27 | AMRS | Amyris, Inc. | Valiasek Kathleen | CFO | P - Purchase | $4.37 | +23,000 | 251,630 | +10% | +$100,574 | ||||||
2018-11-13 | AP | Ampco Pittsburgh Corp | McBrayer Brett | CEO | P - Purchase | $4.75 | +4,000 | 25,884 | +18% | +$19,000 | ||||||
2018-11-13 | AP | Ampco Pittsburgh Corp | Scagline Rodney | Pres of Union Electric | P - Purchase | $4.53 | +8,000 | 26,535 | +43% | +$36,264 | ||||||
2018-11-13 | AP | Ampco Pittsburgh Corp | Kenny Terrence W | Pres,Air, Liq. Proc. Group | P - Purchase | $4.56 | +4,000 | 18,396 | +28% | +$18,248 | ||||||
2018-11-21 | AP | Ampco Pittsburgh Corp | German Michael I | Dir | P - Purchase | $4.26 | +3,000 | 25,266 | +13% | +$12,780 | ||||||
2018-11-30 | AP | Ampco Pittsburgh Corp | Abel James J | Dir | P - Purchase | $4.12 | +7,000 | 26,266 | +36% | +$28,818 | ||||||
| M | 2018-11-19 | APEN | Apollo Endosurgery, Inc. | Stonepine Capital, L.P. | 10% | P - Purchase | $3.41 | +57,430 | 2,935,426 | +2% | +$195,924 | |||||
2018-12-06 | APVO | Aptevo Therapeutics Inc. | Maddux Randy Joe | SVP Operations | P - Purchase | $2.37 | +5,000 | 30,000 | +20% | +$11,850 | ||||||
2018-12-04 | APVO | Aptevo Therapeutics Inc. | White Marvin L | Pres, CEO | P - Purchase | $2.38 | +10,000 | 203,603 | +5% | +$23,800 | ||||||
| M | 2018-11-28 | ARPO | Aerpio Pharmaceuticals, Inc. | Satter Muneer A | Dir, 10% | P - Purchase | $1.98 | +60,000 | 5,138,017 | +1% | +$118,524 | |||||
| M | 2018-12-03 | ARPO | Aerpio Pharmaceuticals, Inc. | Satter Muneer A | Dir, 10% | P - Purchase | $2.09 | +60,000 | 5,198,017 | +1% | +$125,352 | |||||
| M | 2018-11-09 | ARPO | Aerpio Pharmaceuticals, Inc. | Hoffman Stephen J | CEO | P - Purchase | $2.01 | +31,967 | 31,967 | New | +$64,136 | |||||
| DM | 2018-11-19 | ARTW | Arts Way Manufacturing Co Inc | McConnell J Ward Jr | Dir, 10% | P - Purchase | $2.25 | +5,839 | 1,824,948 | 0% | +$13,138 | |||||
| DM | 2018-11-15 | ARTW | Arts Way Manufacturing Co Inc | McConnell J Ward Jr | Dir, 10% | P - Purchase | $2.25 | +30,295 | 1,819,109 | +2% | +$68,164 | |||||
2018-11-19 | ARTX | Arotech Corp | Kutler Jon B | CHAIRMAN OF THE BOARD | P - Purchase | $2.62 | +20,000 | 1,850,968 | +1% | +$52,495 | ||||||
| M | 2018-11-08 | ARTX | Arotech Corp | Kutler Jon B | CHAIRMAN OF THE BOARD | P - Purchase | $2.86 | +15,000 | 1,830,968 | +1% | +$42,889 | |||||
2018-11-12 | ARTX | Arotech Corp | Cappell Kenneth W | Dir | P - Purchase | $2.80 | +10,000 | 104,702 | +11% | +$27,956 | ||||||
2018-11-15 | ASG | Liberty All Star Growth Fund Inc. | Usifer Maureen K | Trustee | P - Purchase | $4.86 | +4,000 | 4,000 | New | +$19,440 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Makower Joshua | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Growth Equity Opportunities Iv, LLC | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Sonsini Peter W. | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Growth Equity Opportunities Iv, LLC | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Makhzoumi Mohamad | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Florence Anthony A. Jr. | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Sonsini Peter W. | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Baskett Forest | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Sandell Scott D | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Barris Peter J | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Barris Peter J | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Mott David M | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Baskett Forest | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Makower Joshua | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Growth Equity Opportunities Iv, LLC | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Florence Anthony A. Jr. | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Makhzoumi Mohamad | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Makhzoumi Mohamad | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Sonsini Peter W. | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Florence Anthony A. Jr. | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Makower Joshua | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Sandell Scott D | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Baskett Forest | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Mott David M | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
| M | 2018-11-15 | AVEO | Aveo Pharmaceuticals Inc | Mott David M | 10% | P - Purchase | $1.86 | +1,200,000 | 19,898,038 | +6% | +$2,237,971 | |||||
| M | 2018-11-28 | AVEO | Aveo Pharmaceuticals Inc | Barris Peter J | 10% | P - Purchase | $1.98 | +96,400 | 20,164,438 | 0% | +$190,891 | |||||
2018-11-20 | AVEO | Aveo Pharmaceuticals Inc | Sandell Scott D | 10% | P - Purchase | $1.98 | +170,000 | 20,068,038 | +1% | +$336,107 | ||||||
2018-10-25 | AXP.A | Airxpanders Inc | Cheskin Barry | Dir | P - Purchase | $0.17 | +299,060 | 446,598 | +203% | +$49,943 | ||||||
| D | 2018-11-09 | BBLS | Petrolia Energy Corp | Oppenheim Joel Martin | Dir | P - Purchase | $0.06 | +175,932 | 12,902,744 | +1% | +$10,556 | |||||
| M | 2018-11-14 | BCDA | Biocardia, Inc. | Altman Peter | Pres, CEO | P - Purchase | $2.34 | +6,400 | 729,792 | +1% | +$14,984 | |||||
2018-11-26 | BDR | Blonder Tongue Laboratories Inc | Grauch Edward Rowland | EVP, COO | P - Purchase | $1.09 | +27,568 | 0 | -100% | +$30,093 | ||||||
| M | 2018-11-29 | BDR | Blonder Tongue Laboratories Inc | Scharmett Gary P | Dir | P - Purchase | $1.23 | +12,010 | 268,364 | +5% | +$14,752 | |||||
2018-12-04 | BDR | Blonder Tongue Laboratories Inc | Grauch Edward Rowland | EVP, COO | P - Purchase | $1.14 | +20,239 | 140,024 | +17% | +$23,068 | ||||||
2018-11-28 | BDR | Blonder Tongue Laboratories Inc | Shea Steven L | Dir | P - Purchase | $1.15 | +30,000 | 387,126 | +8% | +$34,584 | ||||||
2018-11-12 | BFGC | Bullfrog Gold Corp. | Beling David Coates | CEO, 10% | P - Purchase | $0.05 | +500,000 | 28,387,204 | +2% | +$23,000 | ||||||
2018-11-12 | BFGC | Bullfrog Gold Corp. | Lindsay Alan P. | Dir | P - Purchase | $0.05 | +500,000 | 7,658,859 | +7% | +$23,000 | ||||||
2018-11-12 | BFGC | Bullfrog Gold Corp. | Thygesen Kjeld | Dir | P - Purchase | $0.05 | +500,000 | 1,000,000 | +100% | +$23,000 | ||||||
2018-11-16 | BIOL | Biolase, Inc | Lord Jonathan T Md | Dir | P - Purchase | $1.36 | +10,000 | 577,145 | +2% | +$13,600 | ||||||
2018-11-09 | BLCM | Bellicum Pharmaceuticals, Inc | Stonehouse Jon P | Dir | P - Purchase | $4.56 | +10,000 | 10,000 | New | +$45,600 | ||||||
2018-12-03 | BLNK | Blink Charging Co. | Engel Donald | Dir | P - Purchase | $2.20 | +45,000 | 374,307 | +14% | +$98,915 | ||||||
| M | 2018-11-20 | BSGM | Biosig Technologies, Inc. | Londoner Kenneth L | CEO, 10% | P - Purchase | $3.71 | +8,500 | 1,819,019 | 0% | +$31,523 | |||||
| M | 2018-11-16 | CAAS | China Automotive Systems Inc | Li Jie | CFO | P - Purchase | $2.09 | +10,000 | 114,997 | +10% | +$20,945 | |||||
| M | 2018-11-13 | CAAS | China Automotive Systems Inc | Li Jie | CFO | P - Purchase | $2.11 | +21,594 | 104,997 | +26% | +$45,457 | |||||
| M | 2018-11-21 | CAAS | China Automotive Systems Inc | Li Jie | CFO | P - Purchase | $2.04 | +10,000 | 124,997 | +9% | +$20,357 | |||||
2018-11-26 | CDE | Coeur Mining, Inc. | Thompson J Kenneth | Dir | P - Purchase | $4.04 | +5,000 | 117,929 | +4% | +$20,180 | ||||||
2018-11-27 | CDR | Cedar Realty Trust, Inc. | Schanzer Bruce J | Pres, Chief Exec. Officer | P - Purchase | $3.40 | +10,840 | 2,152,097 | +1% | +$36,825 | ||||||
| DM | 2018-11-21 | CERC | Cerecor Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $3.59 | +50,000 | 35,800,000 | 0% | +$179,407 | |||||
| DM | 2018-11-13 | CERC | Cerecor Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $3.85 | +31,314 | 35,601,800 | 0% | +$120,578 | |||||
| DM | 2018-11-27 | CERC | Cerecor Inc. | Armistice Capital, LLC | 10% | P - Purchase | $3.51 | +77,803 | 35,955,606 | 0% | +$272,864 | |||||
| DM | 2018-11-16 | CERC | Cerecor Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $3.61 | +49,100 | 35,700,000 | 0% | +$177,293 | |||||
| DM | 2018-11-30 | CERC | Cerecor Inc. | Armistice Capital, LLC | Dir, 10% | P - Purchase | $3.49 | +25,797 | 36,007,200 | 0% | +$90,153 | |||||
| M | 2018-11-07 | CKPT | Checkpoint Therapeutics, Inc. | Rosenwald Lindsay A Md | Dir | P - Purchase | $2.29 | +100,000 | 126,448 | +378% | +$229,211 | |||||
2018-11-19 | CLMT | Calumet Specialty Products Partners, L.P. | William A Anderson | EVP - Sales | P - Purchase | $3.59 | +11,600 | 76,417 | +18% | +$41,650 | ||||||
| M | 2018-11-19 | CLRO | Clearone Inc | Hakimoglu Zeynep | Pres, CEO | P - Purchase | $1.27 | +30,974 | 364,026 | +9% | +$39,337 | |||||
| M | 2018-11-13 | CLRO | Clearone Inc | Hakimoglu Zeynep | Pres, CEO | P - Purchase | $1.25 | +86,439 | 333,046 | +35% | +$107,626 | |||||
| M | 2018-11-23 | CLRO | Clearone Inc | Hakimoglu Zeynep | Pres, CEO | P - Purchase | $1.27 | +116,653 | 480,679 | +32% | +$148,149 | |||||
2018-12-06 | CLSD | Clearside Biomedical, Inc. | Thorp Clay | Dir, 10% | P - Purchase | $1.36 | +8,000 | 3,474,394 | 0% | +$10,880 | ||||||
| DM | 2018-11-27 | CRMD | Cormedix Inc. | Baluch Khoso | CEO | P - Purchase | $1.22 | +25,000 | 228,873 | +12% | +$30,495 | |||||
| D | 2018-11-27 | CRMD | Cormedix Inc. | Cook Robert W. | CFO | P - Purchase | $1.17 | +25,000 | 127,083 | +24% | +$29,213 | |||||
| D | 2018-11-29 | CRMD | Cormedix Inc. | Armstrong Jr. John L. | EVP of Tech Operations | P - Purchase | $1.45 | +250,000 | 288,861 | +643% | +$363,150 | |||||
| D | 2018-11-23 | CRMD | Cormedix Inc. | Kaplan Myron | Dir | P - Purchase | $1.30 | +50,000 | 371,166 | +16% | +$64,795 | |||||
2018-12-04 | CRR | Carbo Ceramics Inc | Kolstad Gary A | Pres, CEO | P - Purchase | $4.77 | +10,000 | 395,651 | +3% | +$47,700 | ||||||
2018-11-29 | CVV | Cvd Equipment Corp | Rosenbaum Leonard A | Pres, CEO, COB, 10% | P - Purchase | $4.57 | +5,000 | 829,768 | +1% | +$22,868 | ||||||
2018-11-12 | CXDO | Crexendo, Inc. | Bash Jeffrey Parr | Dir | P - Purchase | $1.64 | +24,992 | 159,992 | +19% | +$41,059 | ||||||
2018-11-15 | CXDO | Crexendo, Inc. | Mihaylo Steven G | CEO, 10% | P - Purchase | $1.80 | +19,913 | 10,113,819 | 0% | +$35,843 | ||||||
2018-11-09 | DRAD | Digirad Corp | Eberwein Jeffrey E. | Dir | P - Purchase | $1.15 | +25,000 | 544,152 | +5% | +$28,750 | ||||||
| M | 2018-11-15 | DRAD | Digirad Corp | Noble David James | COO | P - Purchase | $1.05 | +15,842 | 35,000 | +83% | +$16,662 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |